Stop TB Partnership’s Post

The Make in India initiative has been pivotal in revolutionizing healthcare solutions, especially in combating diseases like tuberculosis (TB). Introducing a Make in India device for screening and testing TB patients is a significant step towards addressing the low detection rates prevalent in the country. By leveraging indigenous manufacturing capabilities, this device can offer rapid molecular testing, which is crucial for early and accurate diagnosis of TB. The collaboration between Stop TB Partnership, USAID's iNTP, and the Make in India initiative ensures that cutting-edge technology is made accessible even in peripheral healthcare facilities, reaching communities that need it the most. The deployment of Truenat systems across Nigeria exemplifies the effectiveness of this approach. Bringing molecular testing closer to the grassroots level enhances accessibility and enables timely intervention. With improved diagnosis rates, healthcare providers can initiate appropriate treatment protocols promptly, reducing the spread of TB and saving lives. This Make in India product not only addresses a critical healthcare need but also underscores the potential of indigenous innovation to drive positive change in public health outcomes, not just within India but globally. Molbio Diagnostics Sriram Natarajan EY

Enhancing Tuberculosis Detection in the DRC WHO calls for “meaningful community engagement” as “critical to improve the reach and sustainability of TB services and accelerate progress towards ending TB by 2030”.   We're proud to share our latest achievements in the Democratic Republic of the Congo (DRC) with our new technical brief on tuberculosis detection.   Key Highlights: Improved Diagnostic Capacity: We've strengthened laboratory networks and ensured the availability of essential diagnostic tools.   Capacity Building: Extensive training for healthcare professionals, enhancing their ability to diagnose and manage TB effectively. 44 dedicated community relays and chief nurses reached over 31,000 community members, providing vital TB information and screening for symptoms.   Community Engagement: Innovative approaches to raise awareness and increase community participation in TB detection and treatment.   These efforts are pivotal in the fight against TB, ensuring timely and accurate diagnosis, which is crucial for effective treatment and control of the disease.   Read the full technical brief to learn more about our comprehensive strategies and impactful results: https://lnkd.in/emZnXcz6   #HealthSystems #Tuberculosis #GlobalHealth #MTaPS #DRC #HealthcareInnovation

#NewsAlert: The The Global Fund Fund to Fight AIDS, Tuberculosis and Malaria and the Stop TB Partnership signed a new collaboration framework with the aim of increasing momentum towards ending TB in low- and middle-income countries by 2030! Highlights of the new four-year agreement: 1. Commit to increase collaboration on a wide spectrum of advocacy, policy, technical & programmatic areas. 2. Support countries to early diagnose and treat all people with TB, including drug-susceptible TB and #DRTB. 3. Continue the work in breaking the gender- and human rights-related barriers that prevent people with TB from accessing the services they need, and to address TB stigma. 4. Boost TB preventive treatment through improved access to quality-assured, affordable medicines and diagnostics, as well as by driving innovation and accelerating new product introduction. 5. Continue to work on strengthening critical elements of the health systems in the affected countries: 📣 Supporting community health workers 📣 Improving access to the latest @WHO - recommended diagnosis  📣 Enhance use of data for decision-making 📣 Strengthening supply chains, and pursuing integrated approaches, including through primary health care, to enable the delivery of critical services to people with all forms of TB.  #EndTB #YesWeCanEndTB Peter Sands Lucica Ditiu

Tuberculosis (TB) remains a significant public health challenge in Nigeria, with the country ranking among the highest TB burden countries globally. The disease not only poses a threat to individuals but also strains healthcare systems and economic development efforts. In response to this pressing issue, both governmental bodies and non-governmental organizations (NGOs) #Tuberculosis(TB)remainsasignificantpublichealthchallengeinNigeria

Access to health care is crucial to preventing diseases like tuberculosis (TB). In Bangladesh, scientists and nonprofits are joining forces to bring innovative solutions like mobile X-ray machines to communities most likely to have TB. These portable tools help to detect the disease earlier and provide lifesaving care to people who need it most. As researchers and leaders, we need to support efforts like these and advocate for increased access to quality care everywhere. https://lnkd.in/eca4Hq_d 

Tuberculosis (TB) remains a significant public health challenge in Nigeria, with the country ranking among the highest TB burden countries globally. The disease not only poses a threat to individuals but also strains healthcare systems and economic development efforts. In response to this pressing issue, both governmental bodies and non-governmental organizations (NGOs) #Tuberculosis(TB)remainsasignificantpublichealthchallengeinNigeria

New global tuberculosis (TB) data analysis reveals that lower income countries are disproportionately affected by TB, compared to high-income countries. ⚖️ Dr Kobto G. Koura, Director of TB and co-author: “We need greater equity for low- and middle-income countries in the investment made in holistic approaches, which incorporate evidence-based interventions (like active case-finding), strengthening health systems and addressing social determinants that drive TB transmission and progression. 🔍 The Union analysed data from 208 countries and islands between 1995 and 2022. 📜 The paper was recently published in the Tropical Medicine and Infectious Disease journal and was the cover story of the issue. Read more: https://lnkd.in/e9MgjKVt

This year’s World malaria report highlights the need for an accelerated and more inclusive response to #malaria, with an emphasis on reaching underserved populations. This includes the smallest of babies, who currently lack access to quality-approved medicines.    To help change this, MMV and Novartis are developing a novel treatment for babies under 5 kg. The prevalence of the disease in this age and weight group is poorly understood, and it is therefore often misdiagnosed, making the CALINA study an important step towards expanding the antimalarial toolbox with medicines tailored to the needs of neonates.    Learn more: bit.ly/3Zyy1ew 

TB Stakeholders! Ending tuberculosis (TB) requires a fundamental shift in how all stakeholders think and act, driven by a sense of urgency for improving access and quality in TB prevention and care. Time and quality are of the essence. We must recognize and embrace this urgency within our own ranks and advocate the same throughout our networks, ensuring a coordinated and compelling message. It is unacceptable that access to rapid molecular diagnosis remains below 50%, and that access to TB preventive treatment (TPT) among household contacts is less than 10%. We must urgently utilize the tools and resources currently at our disposal while continuing to push for new innovations, including vaccines. The time to act is now. World Health Organization; Stop TB Partnership; USAID; Unitaid; The Global Fund #EndTB

Just Published | New study led by Menzies PhD student Sarah Cassidy-Seyoum highlights improved strategies are needed to ensure access to radical cure for vivax malaria. Plasmodium vivax remains a significant challenge for malaria elimination due to its dormant liver stages, which can reactivate after initial infection. The study found that current strategies only provide access to adequate treatment for half of the vivax patients because of low referral rates. To improve access to radical cure treatments for vivax malaria improvements in infrastructure and income security are needed. In the short term bringing treatment closer to patients, and equipping community health workers with G6PD tests for effective curative treatment is crucial. Read the full study here - bit.ly/3y6NdWL